title: Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab.
authors.forename: Kirsten E
authors.initials: KE
authors.lastname: Herbert
authors.forename: H Miles
authors.initials: HM
authors.lastname: Prince
authors.forename: David A
authors.initials: DA
authors.lastname: Westerman
mesh_terms: D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000628:therapy; D009894:Opportunistic Infections / Q000821:virology; D010322:Parvoviridae Infections / Q000209:etiology*; D016732:Parvovirus B19, Human; D012010:Red-Cell Aplasia, Pure / Q000821:virology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000074323:Alemtuzumab